樱桃视频

October 28, 2015

Roche halts diabetes drug trial in blow to pipeline

Roche will stop development of a drug for treating diabetes partly due to its undesired side effects, marking a high-profile setback for the Swiss company outside its cancer drug comfort zone.

October 28, 2015

Implanted drug improves tolerance of sunlight in rare condition

A skin-darkening drug can help protect against serious pain in people with a rare inherited condition that makes them flee sunlight like movie vampires, according to tests in Europe and the U.S.

October 28, 2015

Hormone therapy may pose higher cancer risk in some women

Taking hormones to treat the symptoms of menopause is thought to increase women's risk of breast cancer, but this risk doesn't rise equally in all women, a new study finds.

October 28, 2015

Hospitals overestimate speed of giving clot-busting drugs

Many hospitals overestimate how quickly they give stroke patients a clot-busting treatment designed to help minimize damage, a U.S. study suggests.

October 28, 2015

New anti-depressant similar to 'Special K' party drug

Johnson & Johnson's intranasal drug, called esketamine, is closely related to a pediatric anesthetic called ketamine that has been shown in academic studies to ease symptoms rapidly in such patients, including a reduction in suicidal thoughts. Ketamine is also the active ingredient of the mood-altering party drug known as "Special K."

October 28, 2015

Novartis hands over experimental TB drugs in antibiotic pullback

Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from antibiotics.

October 28, 2015

Synthetic human growth hormones may not help healthy aging

Does human growth hormone have antiaging powers? Or does it contribute to heightened cancer risk and earlier death? The complex science in the area suggests the answer is yes to both.

October 28, 2015

FDA strengthens heart safety warnings on popular pain relievers

Federal health regulators are bolstering warning labels on popular pain relievers to reflect new information about their risks of heart attack and stroke.

October 28, 2015

Study confirms bracelet-like device for acid reflux safe, effective 5 years after implantation

For nearly the past 50 years, primary treatment for acid reflux in the United States has included medications meant to dilute acid that regurgitates from the stomach, as well as a risky procedure that involves wrapping part of the stomach around a lower esophageal muscle.

October 28, 2015

With stimulant, kids with ADHD less likely to injure themselves

When kids with attention-deficit hyperactivity disorder (ADHD) are taking methylphenidate, a stimulant drug, they are less likely to end up in the emergency room with a trauma injury, a new study finds.